Alkermes plc EBITDA
What is the EBITDA of Alkermes plc?
The EBITDA of Alkermes plc is $394.679M
What is the definition of EBITDA?
EBITDA is a company’s earnings before interest, taxes, depreciation, and amortization and is an accounting measure calculated using a company’s net earnings, before interest expenses, taxes, depreciation and amortization are subtracted, as a proxy for a company’s current operating profitability.
ttm (trailing twelve months)
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA of companies in the Health Care sector on NASDAQ compared to Alkermes plc
What does Alkermes plc do?
alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.
Companies with ebitda similar to Alkermes plc
- Damodar Industries has EBITDA of ₨392.384M
- Chinney Investments has EBITDA of HKD$393.365M
- Derichebourg SA has EBITDA of €393.500M
- Asahi Songwon Colors has EBITDA of ₨393.596M
- Shanghai Medicilon has EBITDA of ¥394.231M
- Gran Tierra Inc has EBITDA of $394.425M
- Alkermes plc has EBITDA of $394.679M
- Mukand has EBITDA of ₨394.950M
- Perfect Shape Beauty Technology has EBITDA of HKD$395.002M
- At Home Inc has EBITDA of $395.265M
- Spin Master has EBITDA of $395.300M
- Arcos Dorados Inc has EBITDA of $395.380M
- EPR Properties has EBITDA of $395.493M